Ligand Pharmaceuticals, Inc. (LGND)
206.40
-2.55
(-1.22%)
USD |
NASDAQ |
Mar 05, 16:00
206.05
-0.35
(-0.17%)
After-Hours: 20:00
Ligand Pharmaceuticals Cash from Investing (Quarterly) : -18.10M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Johnson & Johnson | -4.485B |
| Merck & Co., Inc. | -11.20B |
| ADMA Biologics, Inc. | -0.276M |
| Elanco Animal Health, Inc. | -64.00M |
| Ionis Pharmaceuticals, Inc. | -419.50M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 45.92M |
| Cash from Financing (Quarterly) | 8.33M |
| Free Cash Flow | 38.04M |
| Free Cash Flow Per Share (Quarterly) | 2.141 |
| Free Cash Flow to Equity (Quarterly) | 44.76M |
| Free Cash Flow to Firm (Quarterly) | 46.66M |
| Free Cash Flow Yield | 0.91% |